Orpha Biotech
Maglie
About Orpha Biotech
Orpha Biotech is a developer of pharmaceutical drugs using molecular technology designed to treat orphan diseases. They create small-molecule medications to treat juvenile rheumatoid arthritis and cutaneous systemic sclerosis. They use structure-based computational virtual screening and allied docking simulations to discover potential agonists or antagonists.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $282.6K
- Funding stage: Seed
- Last round: Pre-Seed (Sep 2020)
- Website: orphabiotech.it
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/orpha-biotech-171027 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.